Ann: First patient dosed in Phase 1/2 trial of CHM CDH17, page-21

.... using CDH17 as target.

Correct!

Reon, I can already hear / read the other posters thinking, " You 2 get a room asap " and therefore I declare you the winner and I pull my head in.

Regardless of what we think or post, the sp hasn't moved much and the $$$$ problem hasn't solved yet.

Let's combine our postal efforts to make CHM more attractive to non-holders.

My verbal shout, Cheers!

Think I had already one too many.

GLTA